4//SEC Filing
Humer Franz B 4
Accession 0001737287-25-000075
CIK 0001737287other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:03 PM ET
Size
5.7 KB
Accession
0001737287-25-000075
Insider Transaction Report
Form 4
Humer Franz B
Director
Transactions
- Award
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total→ Common Stock (95,400 underlying)
Footnotes (1)
- [F1]Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Mr. Humer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001548072
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:03 PM ET
- Size
- 5.7 KB